84166 Federal Register / Vol. 88, No. 231 / Monday, December 4, 2023 / Notices 

membership, which is bound by Indian 

Preference Act of 1990 (25 U.S.C. 472). 

5. Basis for Nominations 

If you wish to nominate someone for 

appointment to the Advisory Board, 

please do not make the nomination until 

the person has agreed to have his or her 

name submitted to the BIE for this 

purpose. A person can also selfnominate. 

6. Nomination Application 

Please submit a complete application 

form and a copy of the nominee’s 

resume or curriculum vitae to the DFO 

by Wednesday, January 31, 2024. The 

nomination application form can be 

found on the BIE website at https://

www.bie.edu/sites/default/files/inlinefiles/Advisory-Board-MembershipNomination-Form%20%28Expires

%206-30-24%29.pdf. 

7. Information Collection 

This collection of information is 

authorized by OMB Control Number 

1076–0179, ‘‘Solicitation of 

Nominations for the Advisory Board for 

Exceptional Children,’’ with a June 30, 

2024, expiration date. 

(Authority: 5 U.S.C. ch. 10; 20 U.S.C. 1400 

et seq.) 

Bryan Newland, 

Assistant Secretary—Indian Affairs. 

[FR Doc. 2023–26518 Filed 12–1–23; 8:45 am] 

BILLING CODE 4337–15–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1304] 

Bulk Manufacturer of Controlled 

Substances Application: Element 

Materials Technology Santa Rosa 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Element Materials 

Technology Santa Rosa has applied to 

be registered as a bulk manufacturer of 

basic class(es) of controlled 

substance(s). Refer to SUPPLEMENTARY

INFORMATION listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before February 2, 2024. Such 

persons may also file a written request 

for a hearing on the application on or 

before February 2, 2024. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on November 1, 2023, 

Element Materials Technology Santa 

Rosa, 3331 Industrial Drive, Suite B, 

Santa Rosa, California 95403–2062, 

applied to be registered as a bulk 

manufacturer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Oxymorphone ............. 9652 II 

Fentanyl ..................... 9801 II 

The company is a contract 

manufacturer. At the request of the 

company’s customers, it manufactures 

derivatives of the listed controlled 

substances in bulk form. No other 

activities for these drug codes are 

authorized for this registration. 

Claude Redd, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2023–26553 Filed 12–1–23; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1300] 

Importer of Controlled Substances 

Application: Caligor Coghlan Pharma 

Services 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Caligor Coghlan Pharma 

Services, has applied to be registered as 

an importer of basic class(es) of 

controlled substance(s). Refer to 

SUPPLEMENTARY INFORMATION listed 

below for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before January 3, 2024. Such 

persons may also file a written request 

for a hearing on the application on or 

before January 3, 2024. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on October 13, 2023, 

Caligor Coghlan Pharma Services, 1500 

Business Park Drive, Unit B, Bastrop, 

Texas 78602, applied to be registered as 

an importer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Dimethyltryptamine .... 7435 I 

The company plans to import the 

listed controlled substance as finished 

dosage units for use in clinical trials. No 

other activities for these drug codes are 

authorized for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonVerDate Sep<11>2014 19:20 Dec 01, 2023 Jkt 262001 PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 E:\FR\FM\04DEN1.SGM 04DEN1

ddrumheller on DSK120RN23PROD with NOTICES1

I I 

I I